Treatment of Pulmonary Hypertension in Patients with Connective Tissue Disease and Interstitial Lung Disease
BACKGROUND: Pulmonary hypertension (PH) in patients with connective tissue disease (CTD) can occur in isolation or concomitantly with interstitial lung disease (ILD). Targeted therapies for PH can mitigate clinical deterioration in CTD patients with isolated PH; however, the effect of these therapie...
Saved in:
| Main Authors: | Shikha Mittoo, Thomas Jacob, Andrea Craig, Zoheir Bshouty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2010/686098 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Selexipag Treatment in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease
by: Chebly Dagher, et al.
Published: (2025-06-01) -
Vascular Compromise and Hemodynamics in Pulmonary Arterial Hypertension: Model Predictions
by: Zoheir Bshouty
Published: (2012-01-01) -
Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
by: Hassan Alfraidi, et al.
Published: (2018-01-01) -
Lung transplantation in connective tissue disease associated interstitial lung disease
by: Srinivas Rajagopala, et al.
Published: (2021-01-01) -
Imaging in connective tissue disease-associated interstitial lung disease
by: Praveen P G. Rao, et al.
Published: (2021-01-01)